Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06246110 |
| Title | A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Eikon Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Medstar Franklin Square Cancer Center at Loch Raven Campus | NOT_YET_RECRUITING | Baltimore | Maryland | 21237 | United States | Details |
| Cancer and Blood Specialists of New York, White Plains Hospital | RECRUITING | White Plains | New York | 10601 | United States | Details |